These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9117460)

  • 1. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study.
    Schreiber GB; Murphy EL; Horton JA; Wright DJ; Garfein R; Chien HC; Nass CC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Mar; 14(3):263-71. PubMed ID: 9117460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Seropositivity for human T-lymphotropic virus types I and II among donors at the Municipal Blood Bank of Caracas and associated risk factors].
    León G; Quirós AM; López JL; Hung M; Díaz AM; Goncalves J; Da Costa O; Hernández T; Chirinos M; Gómez R
    Rev Panam Salud Publica; 2003; 13(2-3):117-23. PubMed ID: 12744787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.
    Busch MP; Laycock M; Kleinman SH; Wages JW; Calabro M; Kaplan JE; Khabbaz RF; Hollingsworth CG
    Blood; 1994 Feb; 83(4):1143-8. PubMed ID: 8111054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group.
    Kaplan JE; Khabbaz RF; Murphy EL; Hermansen S; Roberts C; Lal R; Heneine W; Wright D; Matijas L; Thomson R; Rudolph D; Switzer WM; Kleinman S; Busch M; Schreiber GB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):193-201. PubMed ID: 8680892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.
    Murphy EL; Watanabe K; Nass CC; Ownby H; Williams A; Nemo G
    J Infect Dis; 1999 Dec; 180(6):1777-83. PubMed ID: 10558931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.
    Murphy EL; Lee TH; Chafets D; Nass CC; Wang B; Loughlin K; Smith D;
    J Infect Dis; 2004 Aug; 190(3):504-10. PubMed ID: 15243924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood donor testing for HIV-I/II and HTLV-I/II.
    Ness PM; Nass CC
    Arch Pathol Lab Med; 1994 Apr; 118(4):337-41. PubMed ID: 7909428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors.
    O'Brien SF; Goldman M; Scalia V; Yi QL; Fan W; Xi G; Dines IR; Fearon MA
    Transfus Med; 2013 Oct; 23(5):358-66. PubMed ID: 23859527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American blood donors seropositive for human T-lymphotropic virus types I/II exhibit normal lymphocyte subsets.
    Prince HE
    Transfusion; 1990; 30(9):787-90. PubMed ID: 2238029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of Human T lymphotropic virus 1 (HTLV-1) Cosmopolitan subtype Transcontinental subgroup (Aa) and HTLV-2 subtype b in blood donors of Corrientes].
    Borda MA; Svibel GR; Biglione MM; Berini CA
    Rev Argent Microbiol; 2019; 51(4):307-315. PubMed ID: 30935721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.
    Williams AE; Fang CT; Slamon DJ; Poiesz BJ; Sandler SG; Darr WF; Shulman G; McGowan EI; Douglas DK; Bowman RJ
    Science; 1988 Apr; 240(4852):643-6. PubMed ID: 2896386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of human T cell lymphotropic virus (HTLV) type II by transfusion of HTLV-I-screened blood products.
    Rios M; Khabbaz RF; Kaplan JE; Hall WW; Kessler D; Bianco C
    J Infect Dis; 1994 Jul; 170(1):206-10. PubMed ID: 8014501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence and risk factors associated with HTLV-I/II infection in injection drug users in northern New Jersey.
    Freeman RC; Rodriguez GM; French JF
    J Addict Dis; 1995; 14(3):51-66. PubMed ID: 8555279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug users: an age-cohort effect for HTLV-II RFLP type aO.
    Murphy EL; Mahieux R; de Thé G; Tekaia F; Ameti D; Horton J; Gessain A
    Virology; 1998 Mar; 242(2):425-34. PubMed ID: 9514966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-1 and -2 in a first-time blood donor population in Northeastern Brazil: Prevalence, molecular characterization, and evidence of intrafamilial transmission.
    Ribeiro IP; Kozlowski AG; Dias de Matos MA; da Costa E Silva ÁM; Dos Santos Carneiro MA; Vicente ACP; Martins RMB
    J Med Virol; 2018 Oct; 90(10):1651-1657. PubMed ID: 29797609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Human T-lymphotropic virus type 1 and 2 among blood donors in Manaus, Amazonas State, Brazil.
    Morais MPE; Gato CM; Maciel LA; Lalwani P; Costa CA; Lalwani JDB
    Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e80. PubMed ID: 29267588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of human T lymphotropic virus type by polymerase chain reaction and correlation with risk factors in northern California blood donors.
    Eble BE; Busch MP; Guiltinan AM; Khayam-Bashi H; Murphy EL
    J Infect Dis; 1993 Apr; 167(4):954-7. PubMed ID: 8450261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-lymphotropic virus type I screening in volunteer blood donors--United States, 1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Dec; 39(50):915, 921-4. PubMed ID: 1979140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.